Yimei concept stocks all weakened, Aoyuan Meigu closed down
Aoyuan Meigu closed down the limit, Teyi pharmaceutical and golden hair Rabbi all fell more than 5%, and Huadong pharmaceutical, Huaxi biological, Harbin Sanlian, Lanzi and other stocks all weakened one after another.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
Synthetic Biology: Who Will Emerge as the Winner?
The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.
Jun 27, 2022 12:38 PM
Briefing Mar 10, 2022 09:18 PM
· Healthcare
Polish President: the issue of providing fighters to Ukraine should be jointly decided by NATO countries
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Briefing Mar 09, 2022 07:19 PM
Daquan energy: the polysilicon sales volume in the first quarter is expected to increase by 72.33% - 76.98% year-on-year
Healthcare
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM
In-depth
See more
Read next
Insight
In-depth
Insight
In-depth
Automotive · Analysis
Diverse BRI Markets Demand Adaptive Strategies from China’s NEV Industry
Yesterday 05:14 PM
Insight
In-depth
Automotive · Analysis
China Deepens Trade with BRI Partners as NEV Companies Go Global
Yesterday 04:57 PM